lunedì 23 giugno 2014

Edoardo Cignoli : Allergan Rejects Unsolicited Exchange Offer from Valeant

Allergan again rebuffed advances from Valeant Pharmaceuticals, saying that its board has unanimously determined that the unsolicited exchange offer to buy the Botox maker is "grossly inadequate."



via WSJ.com: US Business http://ift.tt/1p9UKJt

Nessun commento:

Posta un commento